BIOGEN INC

BIIB NASDAQ

SuperQueen

not sure if they will get FDA approval anytime soon. Demential money.

jakdemir

BIOGEN INC Long Term Trend

SuperQueen

back to the future ?

KhanhC.Hoang

IF it breaks out of the red zone in its monthly chart, then $800 is possible.

TopMarketGainers

Potential entry above the 200ma @ $280 Target price $300

MarketsRadar

BIIB Daily Chart , Not a High Quality Trade!

freddiegbruh

Ranging -> breakout -> retest -> go? We will see. I cant predict the future. Tail or fade, idc

Vibranium_Capital

its a great longterm play if you got in a while ago! id wait for the top trendline to break to get long but this is a good reward if you use a tight stop on shares. but be careful if support breaks theres no floor on this one. it could be a nasty dump. goodluck :)

CryptoFundManager

You can buy Biogen cheaper than Warren Buffett did! :) The Oracle of Omaha picked up 648,447 shares of Biogen , allocating 0.08% of the equity portfolio to the holding. During the quarter, the stock traded for an average price of $279.04 per share. (yahoo finance) The indicators are mixed, signaling selling intention on the lower timeframes, but Buy signal on the...

Vibranium_Capital

we are looking at 100 dollars of upside after this final top line breaks! dang thanks for the request.. on my watchlist now :) leave a like if you enjoyed my idea <3

tickeron

I found this pattern at tickeron website with the following data: STATUS = Confirmed CURRENT CONFIDENCE = 72% TARGET (EXIT) PRICE = 258.07 USD BREAKOUT (ENTRY) PRICE = 247.08 USD DISTANCE TO TARGET PRICE = 4.85% EMERGED ON = Nov 11, 09:30 AM (EST) CONFIRMED ON = Nov 11, 10:30 AM (EST) WITH CONFIDENCE LEVEL = 87% Once the price breaks out from the top pattern...

monkreet

Simple Price Action TA,

CryptoFundManager

Food and Drug Administration indicate support for Biogen`s Alzheimer drug candidate aducanumab ahead of a committee meeting this week to review its marketing application. On 11/4/2020 Jefferies Financial Group Upgraded the stock price target to $450.00 BIIB has a still low 8.18 P/E ratio, compared with the industry, lot of room to grow. The indicators are overall...

WadeYendall

Massive move today on positive drug new. May to be tough to get an entry on this as I don't want to chase. I will be looking for price to consolidate at the highs with good volume. Not interested if price has wild swings.

UnderwearTrader

FDA meeting is November 6th for Alzheimer's drug

alexriz802

Stock trend for biogen

YouCanTradeYCT

Hey traders, I was searching for potential pivot points for long call opportunities and I came across Biogen NASDAQ:BIIB and thought to myself "Hey! This looks good!"... that is until I saw they're expected to report earnings tomorrow. But otherwise, take a look at the chart above. One thing you will see...is that its been trading within a range. I highlighted...

TechieTrades

ER this week. I think we will retest $270